TBABF yields 2.15% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, TBABF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TBABF + JNJ for your $10,000?
Trelleborg AB (publ) develops, manufactures, and sells engineered polymer solutions for seal, damp, and protect critical applications worldwide. The company offers anti-vibration solutions, including anti-vibration and suspension products, as well as buffers and pads, and cable entry products; boots for transmission, steering gear, and shock absorption applications; bearings and bushings; engineered coated fabrics; engineered molded parts; fenders, docking, and mooring; floatover; and fluid handling solutions. It also provides health and medical; offshore; pipe seals and repair; printing; sealing profiles; sealing; rubber; tunnel seals; wear protection; and wheels and tires solutions. In addition, the company offers tire fitting services; bridge bearings; bridge expansion joints; cable and rubber compounds; downhole; flexible containment; electrical protection; embedded rail system; flat gaskets; grout seals; inflatable; milk liners; and noise and vibration damping solutions. Further, it provides oil sand; rubber flooring; seismic; ship fenders; squeegees; and truck and diesel solutions. Trelleborg AB (publ) was founded in 1905 and is headquartered in Trelleborg, Sweden.
Full TBABF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.